Retatrutide 20 mg
€11.00 per mg
1 Products
Standard
€220,00
/each
3 Products
5% OFF
€209,00
/each
6 Products
10% OFF
€198,00
/each
8 Products
15% OFF
€187,00
/each
Secure payment via
'%3e%3cpath%20d='M780%200H0V500H780V0Z'%20fill='%231434CB'/%3e%3cpath%20d='M489.823%20143.111C442.988%20143.111%20401.134%20167.393%20401.134%20212.256C401.134%20263.706%20475.364%20267.259%20475.364%20293.106C475.364%20303.989%20462.895%20313.731%20441.6%20313.731C411.377%20313.731%20388.789%20300.119%20388.789%20300.119L379.123%20345.391C379.123%20345.391%20405.145%20356.889%20439.692%20356.889C490.898%20356.889%20531.19%20331.415%20531.19%20285.784C531.19%20231.419%20456.652%20227.971%20456.652%20203.981C456.652%20195.455%20466.887%20186.114%20488.122%20186.114C512.081%20186.114%20531.628%20196.014%20531.628%20196.014L541.087%20152.289C541.087%20152.289%20519.818%20143.111%20489.823%20143.111ZM61.3294%20146.411L60.1953%20153.011C60.1953%20153.011%2079.8988%20156.618%2097.645%20163.814C120.495%20172.064%20122.122%20176.868%20125.971%20191.786L167.905%20353.486H224.118L310.719%20146.411H254.635L198.989%20287.202L176.282%20167.861C174.199%20154.203%20163.651%20146.411%20150.74%20146.411H61.3294ZM333.271%20146.411L289.275%20353.486H342.756L386.598%20146.411H333.271ZM631.554%20146.411C618.658%20146.411%20611.825%20153.318%20606.811%20165.386L528.458%20353.486H584.542L595.393%20322.136H663.72L670.318%20353.486H719.805L676.633%20146.411H631.554ZM638.848%20202.356L655.473%20280.061H610.935L638.848%20202.356Z'%20fill='white'/%3e%3c/g%3e%3cdefs%3e%3cclipPath%20id='clip0_6278_125833'%3e%3crect%20width='780'%20height='500'%20fill='white'/%3e%3c/clipPath%3e%3c/defs%3e%3c/svg%3e)
Retatrutide 20 mg research-grade lyophilized peptide powder in a glass vial. Retatrutide (LY3437943) is an investigational multi-receptor peptide agonist that targets GIP, GLP-1 and glucagon receptors, used in experimental models of obesity, glycemic control and metabolic regulation. Currently available on pre-order.
Research Use Only: All products are intended exclusively for laboratory and scientific research. Not for human or veterinary use.
Technical Specifications
Frequently asked questions
Research Overview
Retatrutide is a next-generation multi-agonist peptide that engages GIP, GLP-1 and glucagon receptors simultaneously. It is used in laboratory and preclinical models to study integrated control of body weight, glucose homeostasis and whole-body energy balance.
Primary Research Areas
- Triple GIP/GLP-1/glucagon receptor agonism: mechanistic studies dissecting receptor pharmacology and downstream pathways.
- Obesity & body-weight regulation models: in vivo models exploring changes in body weight, adiposity, and food intake.
- Glycemic control & metabolic health: research on glucose tolerance, insulin dynamics, and hepatic glucose output.
For Research Use Only
This product is intended solely for in-vitro research and laboratory use. Not intended for human consumption, diagnostic or therapeutic purposes.
Safety & Handling
Handle with appropriate protective equipment (gloves, lab coat, eye protection). Store according to product specifications. Consult the Safety Data Sheet (SDS) for full safety instructions.